SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001144204-12-000771
Filing Date
2012-01-05
Accepted
2012-01-05 17:04:53
Documents
3
Period of Report
2011-12-29
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 2.01: Completion of Acquisition or Disposition of Assets
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT v244680_8-k.htm 8-K 54284
2 EXHIBIT 3.1 CERTIFICATE OF DESIGNATION v244680_ex3-1.htm EX-3.1 51131
3 EXHIBIT 10.1 EXCHANGE TRANSACTION AGREEMENT v244680_ex10-1.htm EX-10.1 173592
  Complete submission text file 0001144204-12-000771.txt   280717
Mailing Address 810 SEVENTH AVENUE 4TH FLOOR NEW YORK NY 10019
Business Address 810 SEVENTH AVENUE 4TH FLOOR NEW YORK NY 10019 (212) 582-3950
MANHATTAN PHARMACEUTICALS INC (Filer) CIK: 0001001316 (see all company filings)

IRS No.: 363898269 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-32639 | Film No.: 12512006
SIC: 2834 Pharmaceutical Preparations